Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy

Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy (DPN) remains one of the most common and serious complications of diabetes. Currently, pharmacological agents are limited to treating the pain associated with DPN, and do not address the underlying pathological mechanisms driving nerve damage, thus leaving a significan...

Full description

Bibliographic Details
Main Authors: Gautam Ghatnekar, April Ann Cox, Yves Sagot, Gael Hedou, Christina Grek, Travis Wilkes, Aaron I. Vinik
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-05-01
Series:Frontiers in Endocrinology
Subjects:
diabetic peripheral neuropathy
interleukin-6
nerve regeneration
myokine
neurocytokine
Online Access:http://journal.frontiersin.org/article/10.3389/fendo.2017.00089/full

Internet

http://journal.frontiersin.org/article/10.3389/fendo.2017.00089/full

Similar Items